PATENT CLAIM ANALYSIS

Application Number: 15764724
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "480000"]

Abstract:
Provided herein, inter alia, are compositions and methods useful for treating hyperproliferative diseases, including cancer and non-malignant hyperproliferative diseases.

Claim (Index 73):
A method of increasing the level of activity of TSC1 or TSC2 in a cell comprising contacting the cell with an effective amount of a compound, or a pharmaceutically acceptable salt thereof, having the formula: wherein L 1  is a bond, substituted or unsubstituted alkylene, or substituted or unsubstituted heteroalkylene; L 2  is a bond, substituted or unsubstituted heteroalkylene, \u2014NH\u2014, or \u2014O\u2014; R 1  is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R 2  is hydrogen, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

Metadata:
- Claim Count in Document: 51.0
- Percentile: 90.0
- Lexical Diversity: 1.27778
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15531245', '15614278', '15778213', '14849428', '15455727']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8042864575672826
- 35 USC 102 Novelty (BERT): 0.5529945970567081
- Combined Prediction Score: 0.7791572715162252
- Mean Citation Score: 396.943362
- Max Citation Score: 452.23532
- Similarity Product: 306.863469968915

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test